Ferric Maltol with Novell Process and Novell Polymorph
The UK’s Competition and Marketing Authority (CMA) has provisionally found that sellers of the antibiotic…
Norgine has signed a deal with Shield Therapeutics allowing it to commercialise iron deficiency therapy Feraccru in Europe, Australia and New Zealand.
Market Place
Share
Share
